'Dangerous Drugs' Category
By Simmons Hanly Conroy | March 7, 2014
FDA Runs First Widespread Quality & Safety Evaluation on Generic Drugs
More than 80 percent of prescription drugs in the U.S. are being tested by the Food and Drug Administration (FDA) in its first widespread safety and quality evaluation. The effort will examine… Read More
By Simmons Hanly Conroy | February 28, 2014
Pharmaceutical News Wrap Up: February 2014
The pharmaceutical lawyers at the Firm are committed to keeping you up-to-date on the latest pharmaceutical news. Below is a short list of some of the most recent headlines concerning FDA recalls,… Read More
By Simmons Hanly Conroy | February 24, 2014
Studies Point to Inconsistencies in FDA Approval Process
Three new studies took a deeper look into the U.S. Food and Drug Administration (FDA) regulatory process. Results from the studies found that FDA approval does not necessarily mean the medication or… Read More
By Simmons Hanly Conroy | February 14, 2014
Study Finds Antioxidant Supplements May Accelerate Cancer Growth
Two antioxidants, vitamin E and beta carotene may do more harm than good in lung cancer patients, a new study suggests. Researchers showed that, antioxidants accelerated the progression of tumors in mice… Read More
By Simmons Hanly Conroy | February 7, 2014
New Study Verifies Need for Updated Warning Label on Low T Drugs
A recent large study backs up findings from previous smaller studies that found low T treatments increase risk of heart attack, stroke or death among men. The new study analyzed data from… Read More
By Simmons Hanly Conroy | February 5, 2014
Simmons Hanly Conroy Files First Testosterone Treatment Lawsuits, Bloomberg Reports
Attorneys at the Firm filed yesterday the first testosterone treatment lawsuits on behalf of five men against Abbott Laboratoes and AbbVie, Inc. The men range in age from 50 to 63 and… Read More
By Simmons Hanly Conroy | January 31, 2014
FDA Investigating Risk of Testosterone Causing Cardiovascular Events
The U.S. Food & Drug Administration is investigating the risk of testosterone treatments causing an increased rate of cardiovascular events such as heart attacks and stroke, according to a drug safety communication from the… Read More
By Simmons Hanly Conroy | January 30, 2014
Testosterone therapy doubles risk of heart attack, stroke in men
Men taking testosterone therapy face an increased risk of heart attack or stroke, according to new research. The study, titled “Increased Risk of Non-Fatal Myocardial Infarction Following Testosterone Therapy Prescription in Men,” was published… Read More
By Simmons Hanly Conroy | January 24, 2014
Study Finds Sharp Increase in Testosterone Use
Testosterone use among older men has drastically increased over the past decade, with more men being tested for low testosterone levels and subsequently being prescribed low T treatments. According to a new… Read More
By Simmons Hanly Conroy | January 17, 2014
Tighter Control Needed on Prescription Drugs, ACP Says
Prescription painkillers are the most abused type of prescription drugs in the United States. To address this problem, the American College of Physicians released recommended guidelines for preventing painkiller prescription abuse in… Read More